Cambridge Enterprise’s role is to support University staff and students in creating world class societal benefit through commercialisation of their world leading research and scholarship. The three principals channels are supporting consultancy for external organisations, protection and licensing of new ideas and the creation and funding of spin-out companies. Tony’s aspiration for Cambridge Enterprise is to support the full breadth of opportunities across the campus from archaeology to zoology with an ambition worthy of a university of Cambridge’s international standing.
This strategy has resulted in tremendous growth for Cambridge Enterprise; since 2011, its venture funding capacity has grown by 730%, the number of spin-outs created has gone up by 250%, and its consultancy support service has increased by 90% and Tony will talk about how Cambridge Enterprise can support your aspirations for your research to make a difference in the world.
Starting in academia and before coming back into academia, Tony had a long history as a successful technology entrepreneur founding companies including Summit Technology, the pioneer of laser refractive surgery, which was acquired by Nestle Alcon in 2000 for $893 million; publicly-quoted Cambridge technology consultancy Sagentia plc; and Diomed Inc, a pioneer of surgical diode lasers which was acquired by a Angiodynamics Inc in 2008.
Tony is a Fellow of the Institute of Physics and a Member of the Institute of Directors. He joined Cambridge Enterprise as CEO in December 2011.
